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Regulation and Function of Tenascin-C in Heart Valve Homeostasis
Abstract
Tenascin-C (TN-C) interacts with extracellular molecules and plays a role in cell adhesion, signaling, and
differentiation. There is evidence that TN-C is regulated by mechanical forces and since the heart valve is
a highly dynamic structure, it is possible that TN-C is expressed within specific sites within the aortic
valve, as these sites are subject to unique mechanical forces. It is also reasonable to expect differences
in TN-C expression between the pulmonary and the aortic valve because these two locations experience
different levels of mechanical force. Here we compare TN-C expression levels in adult pulmonary versus
aortic valves and determine if different cell types within aortic valves express different amounts of TNC.
Our results indicate that TN-C is expressed in normal post-natal heart valves and expression is higher on
the aortic versus ventricular side of the aortic valve. TN-C expression may be higher in aortic versus
pulmonary valve. SMC, fibroblasts or myofibroblasts may produce TN-C, but endothelial cells appear not
to produce TN-C. These studies will help us in determining the role TN-C plays in normal heart valve
tissue homeostasis and how different cell types react to different mechanical forces.
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Abstract
Tenascin-C (TN-C) interacts with extracellular molecules and plays a role in cell adhesion, signaling, and
differentiation. There is evidence that TN-C is regulated by mechanical forces and since the heart valve
is a highly dynamic structure, it is possible that TN-C is expressed within specific sites within the aortic
valve, as these sites are subject to unique mechanical forces. It is also reasonable to expect differences
in TN-C expression between the pulmonary and the aortic valve because these two locations experience
different levels of mechanical force. Here we compare TN-C expression levels in adult pulmonary versus
aortic valves and determine if different cell types within aortic valves express different amounts of TNC. Our results indicate that TN-C is expressed in normal post-natal heart valves and expression is higher
on the aortic versus ventricular side of the aortic valve. TN-C expression may be higher in aortic versus
pulmonary valve. SMC, fibroblasts or myofibroblasts may produce TN-C, but endothelial cells appear not
to produce TN-C. These studies will help us in determining the role TN-C plays in normal heart valve tissue
homeostasis and how different cell types react to different mechanical forces.

Introduction
Heart valves help control the flow of blood through the
heart’s four chambers. The upper two are the small, round
atria, and the lower two are large, cone-shaped ventricles.
Each ventricle has an inlet valve and an outlet valve to ensure
that blood flow is unidirectional. In the left ventricle, the inlet
valve is the mitral valve, and the outlet valve is the aortic
valve. In the right ventricle, the inlet valve is the tricuspid
valve, and the outlet valve is the pulmonary (pulmonic) valve.
Each valve consists of flaps, which function like a one-way
swinging gate. There are a number of inherited and/or postnatal diseases that are associated with abnormal heart valve
development or disease. Heart valves can malfunction either
by leaking (regurgitation), or by not opening adequately and
partially blocking the flow of blood through the valve (stenosis). Well-known diseases include aortic valve sclerosis
(calcification) and aortic regurgitation.
Every heartbeat has two distinct components: diastole
and systole. During diastole, the heart relaxes and ventricles
fill with blood; then the atria contract and force more blood
into the ventricles. During systole, the ventricles contract and
pump blood to the arteries; then the atria relax and begin filling
blood again. As the valve opens and closes 70 times per minute
on average, heart valves undergo stress fluctuations repeatedly due to the blood flow. In addition to gross fluctuations
in valve movement, it is likely that there are local differences
in tissue biomechanics throughout the valve structure. For
example, folding corrugations form on the aortic surface of
the valve, and at the base of the valve where it connects to the
heart wall. These supplemental biomechanical deformations
are likely to impose additional forces and modes of behavior
on the underlying cells.
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Tenascin-C (TN-C) is a large, secreted glycoprotein that
functions outside the cell within the extracellular matrix. The
domain structure of TN-C allows for interaction with multiple
extracellular molecules and for multiple roles in cell adhesion,
signaling and differentiation. TN-C interacts with the cell surface through numerous receptors, including integrins, which
are used to send signals to the cell interior. These signals can
instruct the cell to grow, migrate, survive, die, or differentiate,
depending upon the cellular and extracellular context (1, 2).
TN-C is synthesized in an ordered fashion at particular sites
during development: It is made in large amounts by certain
tumors (at pathological sites), and is found in restricted tissue
locations in the adult. TN-C is also expressed in normal processes, such as wound healing and nerve regeneration (1, 2).
Usually, however, TN-C is suppressed in normal adult tissues.
For example, TN-C is also expressed within the developing
heart valve (3), and it is highly expressed in diseased valves
where it is believed to promote sclerosis (hardening of the
valve) (4). However, it is not known whether TN-C also plays
a role in normal valve tissue homeostasis.
There is significant evidence that TN-C is regulated by mechanical forces (5). Studies show that hemodynamic stress of
increased pulmonary arterial flow induces TN-C (6). In keeping with this, removal of mechanical stress suppresses TN-C
expression (7). Collectively, these and other studies indicate
that TN-C expression is regulated by tissue biomechanics, and
that this may account for its appearance in settings where it
plays a regenerative role, such as healing wounds. Since the
heart valve is a highly dynamic structure, it is possible that
TN-C is expressed within specific sites within the aortic valve,
because these sites are subject to unique and local mechanical
forces. As well, since the adult pulmonary valve, located in a
low pressure vascular bed, experiences a different level of me-
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chanical force when compared to the adult aortic valve, which
is subject to higher pressures, it is also reasonable to expect
differences in TN-C expression at these two different locations. Thus, a primary goal of this project was to compare TNC expression levels in adult pulmonary versus aortic valves.
Another aim of this research project was to determine whether
different cell types within aortic valves express different
amounts of TN-C. There are believed to be at least 3 different cell types in the aortic valve: The surface of the leaflet
is covered with a layer of endothelial cells (ECs), while
within the valve there are fibroblasts and smooth muscle cells
(SMCs). Importantly, each of these distinct cell types can be
identified using specific markers: ECs (von Williebrand factor), fibroblasts (fibroblast specific protein), and for SMCs
(smooth muscle alpha–actin). By determining which cells
express TN-C in normal heart valves, we may be able to find
out more about the role TN-C plays in normal heart valve
tissue homeostasis and how different cell types react to different mechanical forces.
Since heart valves are highly dynamic structures subjected
to different levels of mechanical force, we hypothesized that
(1) TN-C would be expressed in the post-natal heart valve;
(2) TN-C would be preferentially expressed in aortic versus
pulmonary valve; and (3) TN-C expression would be higher
on the aortic versus ventricular side within the same valve. To
address these hypotheses, we used an immunohistochemical
approach using porcine heart valves and antibodies raised
against TN-C, and cell type specific markers.

Materials

and

Methods

As mentioned above, the primary experimental approach
used throughout the semester was immunohistochemistry using a peroxidase-based approach. Immunohistochemistry is a
method of detecting the presence of specific proteins in cells
or tissues. By conducting immunostaining for TN-C and for
markers that are specific for the 3 different cell types in the
aortic valve (i.e. vWf, fibroblast specific protein, and smooth
muscle alpha-actin), we were able to identify if the different
cells in the valve are surrounded by TN-C. Upon retrieving
normal adult porcine heart valves (Landrace X Yorkshire, ~
250 lbs., castrated), longitudinal and transversal tissue sections
were taken. Longitudinal sections are cut along the Arantii
nodule, while transversal sections are along the closure line
of the valve. To prepare for immunohistochemical analysis,
each sample was then embedded in paraffin, and these were
then sectioned to a thickness of approximately 7 µm. Swine
are particularly convenient to use for research due to their
similarities in body size and with the biology of the human,
in particular with the heart and blood vessels.
The polyclonal primary antibodies used were anti-chicken
TN-C antibody, anti-human von Williebrand factor (vWf) for
ECs, and anti-human S100A4 for fibroblasts. Primary antibodies were applied in dilutions of 1:500 for TN-C, and 1:2000
for vWf. S100A4 was applied in dilutions of 1:100 and 1:200.
Monoclonal mouse anti-smooth muscle actin antibody was
used for immunostaining for smooth muscles cells. This was
applied in 1:500 dilution. Biotin was then added to bind to
the antibody-antigen complex using biotinylated secondary
antibodies. The secondary antibodies (all from Vectastain)
used were biotinylated anti-rabbit IgG (for TN-C, VWf, and
fibroblasts), and biotinylated anti-mouse IgG (SMA). For
negative controls, normal rabbit IgG or normal mouse IgG
was used in place of the primary test antibodies.

Samples were prepared for the immunohistochemistry
by first removing the paraffin from the sections and this was
followed by rehydration of tissue samples. Sections were then
subject to antigen retrieval, which is a method to enhance
exposure of the protein of interest to the applied antibody that
may have been masked by fixation. A pronase digestion solution was used for TN-C and S100A4 immunostaining, while
proteinase-K digestion was used for the vWf immunostaining. For the SMA immunostaining, samples were subjected
to antigen retrieval by placing them in citrate buffer, and then
heating them on a hotplate after which they were allowed to
stand at RT for 30 min. Endogenous peroxidase activity was
blocked with methanol containing 0.3% hydrogen peroxide for
30 min at RT, followed by washing with phosphate-buffered
saline solution (PBS). Nonspecific binding was inhibited with
a solution of 1% BSA in PBS, 0.1% Tw20, and 5% normal
goat serum for 30 min at RT. This is necessary to eliminate
any non-specific adsorption of the primary antibody to tissue
elements. Immunostaining was then carried out by applying
the appropriate concentration of primary antibody to each
sample and incubating overnight at 4°C. For negative controls,
normal rabbit IgG or normal mouse IgG was used in place of
the primary test antibodies. Following incubation, the samples
were washed repeatedly in 1% BSA and .1 % BSA and then
were incubated with their respective biotinylated secondary
antibody for one hour at RT. The antibody-antigen complex is
now bound by a secondary, enzyme-conjugated, antibody. The
avidin-biotin-peroxidase complex (ABC) was then performed
for 30 min at RT. This allows for a complex to form between
the avidin and biotinylated enzymes, enhancing the signal as
the avidin has four binding sites for biotin. The color reaction was developed with the use of diaminobenzidine (DAB),
which is a peroxidase procedure for localizing markers. The
DAB reaction is performed to deposit a brown substrate
where there are peroxidase enzymes present. This reaction
was done for the same amount of time on each sample so that
the level of TN-C expression could be compared between
them. Thus, an assessment of relative TN-C expression can
be completed in qualitative terms according to the resulting
staining intensity from the DAB reaction. Counter-staining
was performed using hematoxylin to visualize and orient
nuclei. Following washing and dehydration, a coverslip was
applied to the section.

Results

and Discussion

To begin to determine whether TN-C is expressed in the
biomechanically active environment of normal adult heart
valves, and whether valves in different vascular beds express
more or less TN-C than one another, we first compared TN-C
expression in post-natal porcine aortic and pulmonary heart
valves (Figure 1). Although TN-C expression (in brown) is
usually suppressed in normal cells, our study showed that TNC is expressed in the normal post-natal adult aortic porcine
valve and it is expressed predominantly on the aortic side. This
is interesting for several reasons: First, most cells are constantly exposed to mechanical forces, but not all of them express
TN-C. The heart is a very dynamic structure, and cells in the
heart experience a significant amount of mechanical stress, and
so this may be part of the reason that TN-C expression does
not turn off in normal cells. In addition, cells on one surface
of the valve leaflet experience a very different hemodynamic
environment than those on the opposite surface. The aortic
side may experience more disruptions than the ventricular
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side due to turbulent blood flow. In fact, this may account for
the fact that calcification and sclerosis occur predominantly
on the aortic side of the valve leaflet, especially since TN-C
has been shown to participate in this process (Refs).  It is also
worthy to note that TN-C is not located on the very edge of
the valve but, instead, there is a gap where TN-C is absent
right along the surface of the valve. This indicates that there
are site-specific differences and TN-C seems to be in discrete
sections within the valve. There is also considerable variation
of TN-C within the same valve of the same individual. This
can be due to varied mechanics or to different cell types that
are in these positions.
It is useful to compare TN-C expression in aortic valve
with the pulmonary valve for several reasons. Structurally,

side. It is important to note that SMA α-actin is a marker for
smooth muscle cells, as well as myofibroblasts. Thus, it would
be useful to find out if these cells that seem to be producing
TN-C are SMCs or myofibroblasts. To distinguish between
the two types of cells, future immunostaining studies will be
performed using myosin heavy chain (MHC) that is frequently
used as an additional marker for smooth muscle.
We also wished to determine whether endothelial cells
(ECs) are in contact with TN-C. To achieve this vWF was

Figure 2: Site-specific differences in SM α-actin in the aortic
valve.
TN-C is expressed at the border of the SM α-actin positive layer.
There appears to be a sub-set of SMCs that make TN-C. Are these really
SMCs or are they myofibroblasts?

Figure 1: TN-C in Ao vs Pulmonary.

Ao Valve: TN-C is strongly expressed towards the Ao side,
and more diffusely within the valve.
Pu. valve: TN-C is moderately expressed towards the outflow
side & less is evident in the interior.

the aorta is thicker than the pulmonary artery. The pulmonary
valve experiences different types of mechanical force than
the aortic valve. Since TN-C has been shown to be controlled
by biomechanical forces, it would reasonable to see differences in TN-C expression because the pulmonary valve is in
a lower pressure vascular bed. Thus, the aortic valve should
express more TN-C if this gene is mechanosensitive. From
examining TN-C expression in pulmonary valves, however,
the results are not conclusive. TN-C levels may be less in
the pulmonary valve than in aortic valves (Figure 1). In the
aortic valve, TN-C is strongly expressed toward the aortic
side, as well as more diffusely within the valve. On the other
hand, in the pulmonary valve TN-C is moderately expressed
toward the outflow side, and is less evident in the interior of
the valve. This suggests that the different types of pressures
and hemodynamic forces that aortic and pulmonary valves
experience may account for differences in TN-C expression.
Regardless of the mechanism, it is clear that in both valves,
more TN-C is expressed on the aortic versus ventricular side.
These results indicate that there are site-specific differences
in TN-C expression, and this could mean either that different
cells are making TN-C at different sites, and/or that external
mechanical influences on the valve differentially regulate
TN-C within the same cell type.
To determine which cell types express TN-C, or are in
contact with TN-C, we performed additional immunohistochemical studies. Initially we stained for smooth muscle cells
(SMCs) using α-actin as a marker. Figure 2 shows that SMCs
are more heavily concentrated on the aortic side (AS) as opposed to the ventricular side (VS). Examining this against the
TN-C immunostaining, TN-C is expressed at the border of
the SM alpha-actin positive layer. However, both the TN-C
and the SM α-actin layer do not match perfectly. Instead, there
seems to be a sub-set of SMCs that make TN-C. In addition,
unlike TN-C expression, SMCs are present on the ventricular
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used as a marker of ECs. As expected, ECs are located on
both surfaces of the valve (Figure 3). Although ECs are
expressed on both sides, it was also clear that vWF staining
was more prominent on the aortic side. This may indicate that
the ECs on each side of the valve are behaving differently
due to differences in tissue biomechanics. Regardless of this
issue, our data show that TN-C is not expressed within the
endothelial layer.
Finally, to determine whether fibroblasts express TN-C,
we examined expression of S100A4. Of note, these experi-

Figure 3: Site-specific differences in vWF in the aortic valve.

ments showed that the aortic side contains more fibroblasts
(Figure 4). Although it resembles and overlaps with both TN-C
and SMCs, the band of fibroblasts does not extend as far into
the valve and is thinner. The fibroblast cells do not match up
precisely with TN-C either. In some cases, fibroblasts are expressed right against the edge of the endothelial layer and this
is where TN-C is absent. Fibroblasts may also be expressed on
the endothelial layer on the surface of the valve. Alternatively,
it is possible that S100A4 also marks ECs.
In summary, TN-C is expressed in normal post-natal heart
valves and expression is higher on the aortic versus ventricular
side of the aortic valve. In addition, TN-C expression may be
higher in aortic versus pulmonary valve. SMC, fibroblasts,
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or myofibroblasts may produce TN-C, but endothelial cells
appear not to produce TN-C. However, these EC studies were

7. Jones PL, Crack J, Rabinovitch M. Regulation of tenascin-C, a vascular smooth
muscle cell survival factor that interacts with the alpha v beta 3 integrin to promote epidermal growth factor receptor phosphorylation and growth. J Cell Biol
1997;139(1):279-93.

Figure 4: S100A4 immunostaining in the Aortic Valve.

of interest, because vWf expression was found to be greater
on the aortic side.

Future Directions
To continue this project, it would be interesting to map
biomechanical forces throughout the valve and determine
how this relates to TN-C expression. By measuring forces
throughout the valve, a comparison could be made between
TN-C expression and different mechanical forces.
Additionally, immunostaining of TN-C in the aortic versus
the pulmonary position will be conducted to begin to determine whether hemodynamic factors differentially regulate
TN-C. Accordingly, expression patterns of TN-C will then be
compared in the aortic and pulmonary position in the heart
valve to see if TN-C is expressed within specific sites.
Finally, it would be interesting to find out what exactly
controls TN-C expression in the valve. Bone morphogenetic
protein-4 (BMP-4) is a growth factor that is expressed on the
aortic side endothelium, and it has been proven that BMP-4
suppresses TN-C expression (Ihida-Stansbury and Jones, unpublished). Given that TN-C is expressed on aortic side but it
stops short of the endothelium layer, BMP-4 may negatively
regulate TN-C within the interior of the valve. There may be a
gradient of BMP-4 that decreases from the endothelium layer
toward the interior of the valve. As BMP-4 levels decrease,
this may correlate with an increasing gradient of TN-C.
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